Aesculap, Osseon partner to distribute VCF treatment devices

Osseon® Therapeutics, Inc. announced today that the company has entered into an International Distribution Agreement with Aesculap AG to distribute its vertebral compression fracture (VCF) treatment devices, including its new CE-Mark approved device – Osseoflex® SB (steerable balloon) in select regions of Europe and Asia.  Aesculap is a division of B. Braun Melsungen, a large medical and pharmaceutical company headquartered in Tuttlingen, Germany.  The Osseoflex® SB and the other Osseon CE Mark approved VCF medical devices offer a complete platform for treatment of spinal fractures.

"Aesculap is a major medical device company known throughout the world as a quality manufacturer and distributor of surgical instruments.  Our new Osseoflex SB (steerable balloon) represents the most precise and controllable treatment device for vertebral compression fracture augmentation currently available to surgeons.  Osseon is very excited to partner with Aesculap to distribute our game-changing Osseoplasty® devices and procedures for VCF treatment to patients throughout Europe and the international community and provide state-of-the-art alternatives to the cumbersome devices and procedures currently used to treat fractures of the thoracic and lumbar spine," said John Stalcup, Ph.D., Osseon's CEO.

Source:

Osseon Therapeutics, Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    B. Braun Melsungen AG. (2019, June 24). Aesculap, Osseon partner to distribute VCF treatment devices. News-Medical. Retrieved on May 24, 2024 from https://www.news-medical.net/news/20120227/Aesculap-Osseon-partner-to-distribute-VCF-treatment-devices.aspx.

  • MLA

    B. Braun Melsungen AG. "Aesculap, Osseon partner to distribute VCF treatment devices". News-Medical. 24 May 2024. <https://www.news-medical.net/news/20120227/Aesculap-Osseon-partner-to-distribute-VCF-treatment-devices.aspx>.

  • Chicago

    B. Braun Melsungen AG. "Aesculap, Osseon partner to distribute VCF treatment devices". News-Medical. https://www.news-medical.net/news/20120227/Aesculap-Osseon-partner-to-distribute-VCF-treatment-devices.aspx. (accessed May 24, 2024).

  • Harvard

    B. Braun Melsungen AG. 2019. Aesculap, Osseon partner to distribute VCF treatment devices. News-Medical, viewed 24 May 2024, https://www.news-medical.net/news/20120227/Aesculap-Osseon-partner-to-distribute-VCF-treatment-devices.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
B. Braun receives FDA approval to use 1g and 2g Ceftazidime in DUPLEX Drug Delivery System